Perspective Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.092; its P/E ratio is -19.83; Perspective Therapeutics is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 2.09M	$ 2.06M	$ 1.83M	$ 1.72M	$ 2.50M
Gross Profit	$ 248.00K	$ 487.00K	$ 403.00K	$ 414.00K	$ 926.00K
EBIT	$ -11.08M	$ -10.85M	$ -3.20M	$ -4.21M	$ -2.11M
EBITDA	$ -10.82M	$ -10.66M	$ -3.20M	$ -4.14M	$ -2.03M
Net Income Common Stockholders	$ -11.11M	$ 26.21M	$ -2.90M	$ -4.07M	$ -2.08M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 28.32M	$ 36.45M	$ 43.76M	$ 54.11M	$ 55.89M
Total Assets	$ 120.14M	$ 127.64M	$ 58.28M	$ 62.54M	$ 64.44M
Total Debt	$ 2.58M	$ 2.12M	$ 392.00K	$ 458.00K	$ 524.00K
Net Debt	$ -25.74M	$ -34.34M	$ -43.37M	$ -53.65M	$ -55.37M
Total Liabilities	$ 11.49M	$ 9.62M	$ 3.27M	$ 4.84M	$ 3.16M
Stockholders Equity	$ 108.65M	$ 118.03M	$ 55.01M	$ 57.70M	$ 61.28M
Cash Flow	-
Free Cash Flow	$ -8.64M	$ 21.18M	-	$ -1.85M	$ -3.00M
Operating Cash Flow	$ -8.07M	$ 21.18M	-	$ -1.76M	$ -2.89M
Investing Cash Flow	$ -573.00K	$ 25.26M	-	$ -35.17M	$ -123.00K
Financing Cash Flow	$ 512.00K	$ -80.00K	-	$ 28.00K	$ 0.00

Currency in USD

Perspective Therapeutics Earnings and Revenue History

Income Statement >

Perspective Therapeutics Debt to Assets

Balance Sheet >

Perspective Therapeutics Cash Flow

Cash Flow >

Perspective Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing